Mesoblast Limited
MEOBF
$1.55
-$0.04-2.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.69% | -2.72% | -16.13% | -25.05% | -12.76% |
| Total Depreciation and Amortization | 100.46% | 67.54% | 37.16% | 19.42% | -19.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.15% | 3.30% | 30.34% | 88.32% | 139.38% |
| Change in Net Operating Assets | -1,371.26% | -2,206.08% | -15.62% | 80.38% | 113.45% |
| Cash from Operations | -40.20% | -20.44% | -3.09% | 14.03% | 43.54% |
| Capital Expenditure | -444.26% | -269.16% | -150.92% | -60.11% | 41.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.73% | -30.05% | 359.77% | 314.77% | 173.38% |
| Cash from Investing | -280.26% | -290.79% | 223.71% | 582.35% | 3,533.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -412.60% | -203.49% | 27.78% | -42.10% | -241.93% |
| Issuance of Common Stock | 530.91% | 264.51% | 154.38% | 0.61% | -67.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -92.45% | -24.64% | 20.21% | 33.40% | 43.54% |
| Cash from Financing | 3,329.17% | 567.13% | 266.03% | 1.58% | -93.28% |
| Foreign Exchange rate Adjustments | 212.11% | 262.35% | 2,080.00% | -169.90% | -264.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 332.63% | 497.92% | 1,279.60% | 37.63% | -344.85% |